Zhejiang Medicine and Puhua Capital Affiliate Form Venture Fund With RMB 210 Million
Puhua Fengqi Phase II (Hangzhou) Venture Capital Fund Partnership (limited partnership) was recently established with capital contributions of RMB 210 million. Its business scope includes venture capital investment, limited to investment in unlisted enterprises.
The partnership is jointly held by Zhejiang Medicine, Zhejiang Puhua Tianqin Equity Investment Management, an affiliate of Puhua Capital, and other parties.
Why this event matters
The event has a measured impact on 2 industrys. The strongest current signal is positive for Private Equity & Venture Capital, with intensity 30/100 and 70% confidence over a medium term horizon.
Private Equity & Venture Capital
- Direction
- positive
- Intensity
- 30
- Confidence
- 70%
- Horizon
- Medium term
Pharmaceuticals
- Direction
- neutral
- Intensity
- 20
- Confidence
- 60%
- Horizon
- Long term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.